Literature DB >> 32920707

ROS-Dependent Lipid Peroxidation and Reliant Antioxidant Ferroptosis-Suppressor-Protein 1 in Rheumatoid Arthritis: a Covert Clue for Potential Therapy.

Zhaoxiang Xie1,2, Haodong Hou2, Dan Luo3, Ran An2, Yunpeng Zhao4, Cheng Qiu5,6.   

Abstract

Rheumatoid arthritis (RA) is a common systemic autoimmune disease with a prevalence of about 1% in which genetic and environmental risk factors both participate in performance of disease. Though several studies contributed in identifying its etiology and pathogenesis, the underlying mechanisms are still unknown. To date, so as palliative for RA, cure strategies are still popular. Hypoxia and oxidative stress are implicated to RA development and subsequent ROS-mediated cell death which is a critical feature for RA progression. As for cell death and lipid peroxidation, ferroptosis is a newly discovered, iron-dependent, and non-apoptotic cell death which draws various attention due to its potential strategies for cancer therapy. Meanwhile, ferroptosis-suppressor-protein 1 (FSP1) is recently identified as a seminal breakthrough owing to its property of versus ferroptosis. By virtue of the complicated research progress on FSP1 with ferroptosis, in this review, we summarize the whole region of relevance between ROS and RA. Taken together, we hypothesize that ROS accompanied with ferroptosis may function as a reciprocal with cell death that interplays with RA; besides, FSP1 might become a potential therapeutic target for RA because of its potential interaction with TNF-α/ROS-positive feedback loop. This review systematically concludes the previous understandings about identification of ROS and FSP1 and, in turn, aims to provide references for further achievements of them and hints on elucidation of its thorough underlying mechanisms.

Entities:  

Keywords:  FSP1; ROS; TNF-α; cell death; ferroptosis; rheumatoid arthritis

Year:  2020        PMID: 32920707     DOI: 10.1007/s10753-020-01338-2

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  53 in total

1.  Chronic Calcium Channel Inhibitor Verapamil Antagonizes TNF-α-Mediated Inflammatory Reaction and Protects Against Inflammatory Arthritis in Mice.

Authors:  Wenhan Wang; Zhong Li; Qingjuan Meng; Pei Zhang; Pengcheng Yan; Zhenbiao Zhang; Hao Zhang; Jingrui Pan; Yujia Zhai; Yaoge Liu; Xiaokai Wang; Weiwei Li; Yunpeng Zhao
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

2.  Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis.

Authors:  Peter C Taylor; Edward C Keystone; Désirée van der Heijde; Michael E Weinblatt; Liliana Del Carmen Morales; Jaime Reyes Gonzaga; Sergey Yakushin; Taeko Ishii; Kahaku Emoto; Scott Beattie; Vipin Arora; Carol Gaich; Terence Rooney; Douglas Schlichting; William L Macias; Stephanie de Bono; Yoshiya Tanaka
Journal:  N Engl J Med       Date:  2017-02-16       Impact factor: 91.245

3.  Decreased plasma beta-carotene levels in women with uterine cervical dysplasias and cancer.

Authors:  P R Palan; S L Romney; M Mikhail; J Basu; S H Vermund
Journal:  J Natl Cancer Inst       Date:  1988-05-18       Impact factor: 13.506

4.  On acting out and its role in the psychoanalytic process.

Authors:  L Grinberg
Journal:  Int J Psychoanal       Date:  1968

5.  Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis.

Authors:  Norma Adán; Jessica Guzmán-Morales; Maria G Ledesma-Colunga; Sonia I Perales-Canales; Andrés Quintanar-Stéphano; Fernando López-Barrera; Isabel Méndez; Bibiana Moreno-Carranza; Jakob Triebel; Nadine Binart; Gonzalo Martínez de la Escalera; Stéphanie Thebault; Carmen Clapp
Journal:  J Clin Invest       Date:  2013-08-01       Impact factor: 14.808

Review 6.  Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.

Authors:  Yunpeng Zhao; Aijun Zhang; Hongxia Du; Shuya Guo; Bin Ning; Shangyou Yang
Journal:  Rheumatol Int       Date:  2011-09-09       Impact factor: 2.631

Review 7.  The multifactorial role of neutrophils in rheumatoid arthritis.

Authors:  Helen L Wright; Robert J Moots; Steven W Edwards
Journal:  Nat Rev Rheumatol       Date:  2014-06-10       Impact factor: 20.543

8.  Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway.

Authors:  Vasanthi S Viswanathan; Matthew J Ryan; Harshil D Dhruv; Shubhroz Gill; Ossia M Eichhoff; Brinton Seashore-Ludlow; Samuel D Kaffenberger; John K Eaton; Kenichi Shimada; Andrew J Aguirre; Srinivas R Viswanathan; Shrikanta Chattopadhyay; Pablo Tamayo; Wan Seok Yang; Matthew G Rees; Sixun Chen; Zarko V Boskovic; Sarah Javaid; Cherrie Huang; Xiaoyun Wu; Yuen-Yi Tseng; Elisabeth M Roider; Dong Gao; James M Cleary; Brian M Wolpin; Jill P Mesirov; Daniel A Haber; Jeffrey A Engelman; Jesse S Boehm; Joanne D Kotz; Cindy S Hon; Yu Chen; William C Hahn; Mitchell P Levesque; John G Doench; Michael E Berens; Alykhan F Shamji; Paul A Clemons; Brent R Stockwell; Stuart L Schreiber
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962

9.  p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells.

Authors:  Amy Tarangelo; Leslie Magtanong; Kathryn T Bieging-Rolett; Yang Li; Jiangbin Ye; Laura D Attardi; Scott J Dixon
Journal:  Cell Rep       Date:  2018-01-16       Impact factor: 9.423

10.  Treating rheumatoid arthritis to target: recommendations of an international task force.

Authors:  Josef S Smolen; Daniel Aletaha; Johannes W J Bijlsma; Ferdinand C Breedveld; Dimitrios Boumpas; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Maarten de Wit; Maxime Dougados; Paul Emery; Alan Gibofsky; Juan Jesus Gomez-Reino; Boulos Haraoui; Joachim Kalden; Edward C Keystone; Tore K Kvien; Iain McInnes; Emilio Martin-Mola; Carlomaurizio Montecucco; Monika Schoels; Désirée van der Heijde; Desirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-03-09       Impact factor: 19.103

View more
  9 in total

Review 1.  The Role of Reactive Oxygen Species in the Rheumatoid Arthritis-Associated Synovial Microenvironment.

Authors:  Xing Wang; Danping Fan; Xiaoxue Cao; Qinbin Ye; Qiong Wang; Mengxiao Zhang; Cheng Xiao
Journal:  Antioxidants (Basel)       Date:  2022-06-13

Review 2.  Ferroptosis and Autoimmune Diseases.

Authors:  Benjamin Lai; Chien-Hsiang Wu; Chao-Yi Wu; Shue-Fen Luo; Jenn-Haung Lai
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

Review 3.  Ferroptosis in Rheumatoid Arthritis: A Potential Therapeutic Strategy.

Authors:  Ting Zhao; Qi Yang; Yujiang Xi; Zhaohu Xie; Jiayan Shen; Zhenmin Li; Zhaofu Li; Dongdong Qin
Journal:  Front Immunol       Date:  2022-02-02       Impact factor: 7.561

Review 4.  Novel Therapeutic Savior for Osteosarcoma: The Endorsement of Ferroptosis.

Authors:  Cheng Qiu; Tianyi Liu; Dan Luo; Dongyang Luan; Lin Cheng; Songgang Wang
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244

Review 5.  Ferroptosis in inflammatory arthritis: A promising future.

Authors:  Siyuan Chang; Mengshi Tang; Bikui Zhang; Daxiong Xiang; Fen Li
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

6.  PSMB5 Alleviates Ulcerative Colitis by Inhibiting ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis.

Authors:  Liang Han; Yanping Hao; Xudong Wu; Duanmin Hu
Journal:  Dis Markers       Date:  2022-08-26       Impact factor: 3.464

Review 7.  Recent advances in enzyme-related biomaterials for arthritis treatment.

Authors:  Xin-Hao Liu; Jia-Ying Ding; Zhi-Heng Zhu; Xi-Chen Wu; Yong-Jia Song; Xiao-Ling Xu; Dao-Fang Ding
Journal:  Front Chem       Date:  2022-08-16       Impact factor: 5.545

Review 8.  Rheumatoid arthritis and mitochondrial homeostasis: The crossroads of metabolism and immunity.

Authors:  Liu Cui; Jing Weiyao; Su Chenghong; Liu Limei; Zhang Xinghua; Yuan Bo; Du Xiaozheng; Wang Haidong
Journal:  Front Med (Lausanne)       Date:  2022-09-23

Review 9.  Advancement in understanding the role of ferroptosis in rheumatoid arthritis.

Authors:  Li Long; Hongmei Guo; Xixi Chen; Yan Liu; Ruyi Wang; Xiaomei Zheng; Xiaobo Huang; Qiao Zhou; Yi Wang
Journal:  Front Physiol       Date:  2022-10-04       Impact factor: 4.755

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.